Brain tumour clinical trial title

DCVax - Brain phase 3 clinical trial for patients with glioblastoma

Brain tumour type

Glioblastoma, 

Website

clinicaltrials.gov/ct2/show/study/NCT00045968?show_locs=Y#locn

Description:

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated. Patients must enter screening at a participating site prior to surgical resection of the tumour. Patients will receive the standard of care, including radiation and Temozolomide therapy and two out of three will additionally receive DCVax-L, with the remaining one third receiving a placebo. Patients randomized to the placebo arm will have the option to receive DCVax-L in a crossover arm upon documented disease progression. (note: DCVax-L when used for patients with brain cancer is sometimes also referred to as DCVax-Brain)

Date added:

Open/Closed: Open

Trial ends:

Provider

Kings College Hospital

Contact details

Gal Maier :


London
SE5 9RS
E-mail: gal.maier@nhs.net
Telephone: 0203 299 7150

Find on Google maps »